-
1
-
-
2142714017
-
Monoclonal antibodies as therapeutic agents for cancer
-
Harris M. Monoclonal antibodies as therapeutic agents for cancer. Lancet Oncol 2004; 5: 292-302
-
(2004)
Lancet Oncol
, vol.5
, pp. 292-302
-
-
Harris, M.1
-
2
-
-
84940979385
-
Gene therapy and peripheral nerve repair: A perspective
-
Hoyng SA, de Winter F, Tannemaat MR, Blits B, Malessy MJ, Verhaagen J. Gene therapy and peripheral nerve repair: a perspective. Front Mol Neurosci 2015; 8: 32
-
(2015)
Front Mol Neurosci
, vol.8
-
-
Hoyng, S.A.1
De Winter, F.2
Tannemaat, M.R.3
Blits, B.4
Malessy, M.J.5
Verhaagen, J.6
-
3
-
-
84937720346
-
Aptamer oligonucleotides: Novel potential therapeutic agents in autoimmune disease
-
Li W, Lan X. Aptamer oligonucleotides: novel potential therapeutic agents in autoimmune disease. Nucleic Acid Ther 2015; 25: 173-9
-
(2015)
Nucleic Acid Ther
, vol.25
, pp. 173-179
-
-
Li, W.1
Lan, X.2
-
4
-
-
77957893294
-
Towards multifunctional, targeted drug delivery systems using mesoporous silica nanoparticles--opportunities & challenges
-
Rosenholm JM, Sahlgren C, Linden M. Towards multifunctional, targeted drug delivery systems using mesoporous silica nanoparticles--opportunities & challenges. Nanoscale 2010; 2: 1870-83
-
(2010)
Nanoscale
, vol.2
, pp. 1870-1883
-
-
Rosenholm, J.M.1
Sahlgren, C.2
Linden, M.3
-
5
-
-
33745513833
-
Role of nanotechnology in targeted drug delivery and imaging: A concise review
-
Koo OM, Rubinstein I, Onyuksel H. Role of nanotechnology in targeted drug delivery and imaging: a concise review. Nanomedicine 2005; 1: 193-212
-
(2005)
Nanomedicine
, vol.1
, pp. 193-212
-
-
Koo, O.M.1
Rubinstein, I.2
Onyuksel, H.3
-
6
-
-
84978478633
-
Enhanced oral bioavailability of felodipine by novel solid self-microemulsifying tablets
-
[Epub ahead of print]
-
Jing B, Wang Z, Yang R, et al. Enhanced oral bioavailability of felodipine by novel solid self-microemulsifying tablets. Drug Dev Ind Pharm 2015; 1-7 [Epub ahead of print]
-
(2015)
Drug Dev Ind Pharm
, pp. 1-7
-
-
Jing, B.1
Wang, Z.2
Yang, R.3
-
7
-
-
84906834359
-
Layered double hydroxide nanocomposite for drug delivery systems; biodistribution, toxicity and drug activity enhancement
-
Kura AU, Hussein MZ, Fakurazi S, Arulselvan P. Layered double hydroxide nanocomposite for drug delivery systems; biodistribution, toxicity and drug activity enhancement. Chem Cent J 2014; 8: 47
-
(2014)
Chem Cent J
, vol.8
-
-
Kura, A.U.1
Hussein, M.Z.2
Fakurazi, S.3
Arulselvan, P.4
-
8
-
-
84938297579
-
Development of orodispersible polymer films containing poorly water soluble active pharmaceutical ingredients with focus on different drug loadings and storage stability
-
Woertz C, Kleinebudde P. Development of orodispersible polymer films containing poorly water soluble active pharmaceutical ingredients with focus on different drug loadings and storage stability. Int J Pharm 2015; 493: 134-45
-
(2015)
Int J Pharm
, vol.493
, pp. 134-145
-
-
Woertz, C.1
Kleinebudde, P.2
-
9
-
-
84938650749
-
Current nanotechnological approaches for an effective delivery of bioactive drug molecules to overcome drug resistance tuberculosis
-
Garg T, Rath G, Murthy RR, Gupta UD, Vatsala PG, Goyal AK. Current nanotechnological approaches for an effective delivery of bioactive drug molecules to overcome drug resistance tuberculosis. Curr Pharm Des 2015; 21: 3076-89
-
(2015)
Curr Pharm Des
, vol.21
, pp. 3076-3089
-
-
Garg, T.1
Rath, G.2
Murthy, R.R.3
Gupta, U.D.4
Vatsala, P.G.5
Goyal, A.K.6
-
10
-
-
33747616656
-
Engineering of therapeutic antibodies to minimize immunogenicity and optimize function
-
Presta LG. Engineering of therapeutic antibodies to minimize immunogenicity and optimize function. Adv Drug Deliv Rev 2006; 58: 640-56
-
(2006)
Adv Drug Deliv Rev
, vol.58
, pp. 640-656
-
-
Presta, L.G.1
-
11
-
-
84908374121
-
Enhancing poxvirus vectors vaccine immunogenicity
-
Garcia-Arriaza J, Esteban M. Enhancing poxvirus vectors vaccine immunogenicity. Hum Vaccin Immunother 2014; 10: 2235-44
-
(2014)
Hum Vaccin Immunother
, vol.10
, pp. 2235-2244
-
-
Garcia-Arriaza, J.1
Esteban, M.2
-
12
-
-
77956514096
-
Unveiling the mechanism of uptake and sub-cellular distribution of cerium oxide nanoparticles
-
Singh S, Kumar A, Karakoti A, Seal S, Self WT. Unveiling the mechanism of uptake and sub-cellular distribution of cerium oxide nanoparticles. Mol Biosyst 2010; 6: 1813-20
-
(2010)
Mol Biosyst
, vol.6
, pp. 1813-1820
-
-
Singh, S.1
Kumar, A.2
Karakoti, A.3
Seal, S.4
Self, W.T.5
-
13
-
-
33847304591
-
Superoxide dismutase mimetic properties exhibited by vacancy engineered ceria nanoparticles
-
Korsvik C, Patil S, Seal S, Self WT. Superoxide dismutase mimetic properties exhibited by vacancy engineered ceria nanoparticles. Chem Commun (Camb) 2007; 1056-8
-
(2007)
Chem Commun (Camb)
, pp. 1056-1058
-
-
Korsvik, C.1
Patil, S.2
Seal, S.3
Self, W.T.4
-
14
-
-
56049106549
-
Comparison of the mechanism of toxicity of zinc oxide and cerium oxide nanoparticles based on dissolution and oxidative stress properties
-
Xia T, Kovochich M, Liong M, et al. Comparison of the mechanism of toxicity of zinc oxide and cerium oxide nanoparticles based on dissolution and oxidative stress properties. ACS Nano 2008; 2: 2121-34
-
(2008)
ACS Nano
, vol.2
, pp. 2121-2134
-
-
Xia, T.1
Kovochich, M.2
Liong, M.3
-
15
-
-
84925763795
-
Feasibility study for intraepidermal delivery of proteins using a solid microneedle array
-
Witting M, Obst K, Pietzsch M, Friess W, Hedtrich S. Feasibility study for intraepidermal delivery of proteins using a solid microneedle array. Int J Pharm 2015; 486: 52-8
-
(2015)
Int J Pharm
, vol.486
, pp. 52-58
-
-
Witting, M.1
Obst, K.2
Pietzsch, M.3
Friess, W.4
Hedtrich, S.5
-
16
-
-
84926177998
-
Use of hollow microneedles for targeted delivery of phenylephrine to treat fecal incontinence
-
Jun H, Han MR, Kang NG, Park JH, Park JH. Use of hollow microneedles for targeted delivery of phenylephrine to treat fecal incontinence. J Control Release 2015; 207: 1-6
-
(2015)
J Control Release
, vol.207
, pp. 1-6
-
-
Jun, H.1
Han, M.R.2
Kang, N.G.3
Park, J.H.4
Park, J.H.5
-
17
-
-
84938814210
-
Fabrication of photomasks consisting microlenses for the production of polymeric microneedle array
-
Kathuria H, Fong MH, Kang L. Fabrication of photomasks consisting microlenses for the production of polymeric microneedle array. Drug Deliv Transl Res 2015; 5: 438-50
-
(2015)
Drug Deliv Transl Res
, vol.5
, pp. 438-450
-
-
Kathuria, H.1
Fong, M.H.2
Kang, L.3
-
18
-
-
84925307572
-
Drug coated microneedles for minimally-invasive treatment of oral carcinomas: Development and in vitro evaluation
-
Ma Y, Boese SE, Luo Z, Nitin N, Gill HS. Drug coated microneedles for minimally-invasive treatment of oral carcinomas: development and in vitro evaluation. Biomed Microdevices 2015; 17: 44
-
(2015)
Biomed Microdevices
, vol.17
-
-
Ma, Y.1
Boese, S.E.2
Luo, Z.3
Nitin, N.4
Gill, H.S.5
-
19
-
-
84895558909
-
Design and physicochemical characterisation of novel dissolving polymeric microneedle arrays for transdermal delivery of high dose, low molecular weight drugs
-
McCrudden MT, Alkilani AZ, McCrudden CM, et al. Design and physicochemical characterisation of novel dissolving polymeric microneedle arrays for transdermal delivery of high dose, low molecular weight drugs. J Control Release 2014; 180: 71-80
-
(2014)
J Control Release
, vol.180
, pp. 71-80
-
-
McCrudden, M.T.1
Alkilani, A.Z.2
McCrudden, C.M.3
-
20
-
-
84895776475
-
Vaccine delivery to the oral cavity using coated microneedles induces systemic and mucosal immunity
-
Ma Y, Tao W, Krebs SJ, Sutton WF, Haigwood NL, Gill HS. Vaccine delivery to the oral cavity using coated microneedles induces systemic and mucosal immunity. Pharm Res 2014; 31: 2393-403
-
(2014)
Pharm Res
, vol.31
, pp. 2393-2403
-
-
Ma, Y.1
Tao, W.2
Krebs, S.J.3
Sutton, W.F.4
Haigwood, N.L.5
Gill, H.S.6
-
21
-
-
84904253335
-
Direct microneedle array fabrication off a photomask to deliver collagen through skin
-
Kochhar JS, Anbalagan P, Shelar SB, Neo JK, Iliescu C, Kang L. Direct microneedle array fabrication off a photomask to deliver collagen through skin. Pharm Res 2014; 31: 1724-34
-
(2014)
Pharm Res
, vol.31
, pp. 1724-1734
-
-
Kochhar, J.S.1
Anbalagan, P.2
Shelar, S.B.3
Neo, J.K.4
Iliescu, C.5
Kang, L.6
-
22
-
-
84928940964
-
Clinical study and stability assessment of a novel transcutaneous influenza vaccination using a dissolving microneedle patch
-
Hirobe S, Azukizawa H, Hanafusa T, et al. Clinical study and stability assessment of a novel transcutaneous influenza vaccination using a dissolving microneedle patch. Biomaterials 2015; 57: 50-8
-
(2015)
Biomaterials
, vol.57
, pp. 50-58
-
-
Hirobe, S.1
Azukizawa, H.2
Hanafusa, T.3
-
23
-
-
84870659751
-
Pocketed microneedles for rapid delivery of a liquid-state botulinum toxin A formulation into human skin
-
Torrisi BM, Zarnitsyn V, Prausnitz MR, et al. Pocketed microneedles for rapid delivery of a liquid-state botulinum toxin A formulation into human skin. J Control Release 2013; 165: 146-52
-
(2013)
J Control Release
, vol.165
, pp. 146-152
-
-
Torrisi, B.M.1
Zarnitsyn, V.2
Prausnitz, M.R.3
-
24
-
-
78651248517
-
Rapid intradermal delivery of liquid formulations using a hollow microstructured array
-
Burton SA, Ng CY, Simmers R, et al. Rapid intradermal delivery of liquid formulations using a hollow microstructured array. Pharm Res 2011; 28: 31-40
-
(2011)
Pharm Res
, vol.28
, pp. 31-40
-
-
Burton, S.A.1
Ng, C.Y.2
Simmers, R.3
-
25
-
-
84904498025
-
Microneedle enhanced delivery of cosmeceutically relevant peptides in human skin
-
Mohammed YH, Yamada M, Lin LL, et al. Microneedle enhanced delivery of cosmeceutically relevant peptides in human skin. PLoS One 2014; 9: e101956
-
(2014)
Plos One
, vol.9
-
-
Mohammed, Y.H.1
Yamada, M.2
Lin, L.L.3
-
26
-
-
84896722028
-
Microneedle-based drug delivery systems for transdermal route
-
Pierre MB, Rossetti FC. Microneedle-based drug delivery systems for transdermal route. Curr Drug Targets 2014; 15: 281-91
-
(2014)
Curr Drug Targets
, vol.15
, pp. 281-291
-
-
Pierre, M.B.1
Rossetti, F.C.2
-
28
-
-
84904351599
-
Electroporation-based technologies for medicine: Principles, applications, and challenges
-
Yarmush ML, Golberg A, Sersa G, Kotnik T, Miklavcic D. Electroporation-based technologies for medicine: principles, applications, and challenges. Annu Rev Biomed Eng 2014; 16: 295-320
-
(2014)
Annu Rev Biomed Eng
, vol.16
, pp. 295-320
-
-
Yarmush, M.L.1
Golberg, A.2
Sersa, G.3
Kotnik, T.4
Miklavcic, D.5
-
29
-
-
0037383050
-
Electroporation: Theory and methods, perspectives for drug delivery, gene therapy and research
-
Gehl J. Electroporation: theory and methods, perspectives for drug delivery, gene therapy and research. Acta Physiol Scand 2003; 177: 437-47
-
(2003)
Acta Physiol Scand
, vol.177
, pp. 437-447
-
-
Gehl, J.1
-
30
-
-
84888341466
-
Skin electroporation for transdermal drug delivery: The influence of the order of different square wave electric pulses
-
Zorec B, Becker S, Rebersek M, Miklavcic D, Pavselj N. Skin electroporation for transdermal drug delivery: the influence of the order of different square wave electric pulses. Int J Pharm 2013; 457: 214-23
-
(2013)
Int J Pharm
, vol.457
, pp. 214-223
-
-
Zorec, B.1
Becker, S.2
Rebersek, M.3
Miklavcic, D.4
Pavselj, N.5
-
31
-
-
68249115720
-
Human skin permeation of 3-O-alkyl carbamate prodrugs of naltrexone
-
Vaddi HK, Banks SL, Chen J, Hammell DC, Crooks PA, Stinchcomb AL. Human skin permeation of 3-O-alkyl carbamate prodrugs of naltrexone. J Pharm Sci 2009; 98: 2611-25
-
(2009)
J Pharm Sci
, vol.98
, pp. 2611-2625
-
-
Vaddi, H.K.1
Banks, S.L.2
Chen, J.3
Hammell, D.C.4
Crooks, P.A.5
Stinchcomb, A.L.6
-
32
-
-
70350506118
-
Soft alkyl ether prodrugs of a model phenolic drug: The effect of incorporation of ethyleneoxy groups on transdermal delivery
-
Thomas JD, Majumdar S, Sloan KB. Soft alkyl ether prodrugs of a model phenolic drug: the effect of incorporation of ethyleneoxy groups on transdermal delivery. Molecules 2009; 14: 4231-45
-
(2009)
Molecules
, vol.14
, pp. 4231-4245
-
-
Thomas, J.D.1
Majumdar, S.2
Sloan, K.B.3
-
33
-
-
0029807938
-
Transdermal delivery of peptides by iontophoresis
-
Hirvonen J, Kalia YN, Guy RH. Transdermal delivery of peptides by iontophoresis. Nat Biotechnol 1996; 14: 1710-3
-
(1996)
Nat Biotechnol
, vol.14
, pp. 1710-1713
-
-
Hirvonen, J.1
Kalia, Y.N.2
Guy, R.H.3
-
34
-
-
84938077636
-
Iontophoresis of minoxidil sulphate loaded microparticles, a strategy for follicular drug targeting?
-
Gelfuso GM, Barros MA, Delgado-Charro MB, Guy RH, Lopez RF. Iontophoresis of minoxidil sulphate loaded microparticles, a strategy for follicular drug targeting? Colloids Surf B Biointerfaces 2015; 134: 408-412
-
(2015)
Colloids Surf B Biointerfaces
, vol.134
, pp. 408-412
-
-
Gelfuso, G.M.1
Barros, M.A.2
Delgado-Charro, M.B.3
Guy, R.H.4
Lopez, R.F.5
-
35
-
-
84920830828
-
Potential of combined ultrasound and microneedles for enhanced transdermal drug permeation: A review
-
Han T, Das DB. Potential of combined ultrasound and microneedles for enhanced transdermal drug permeation: a review. Eur J Pharm Biopharm 2015; 89: 312-28
-
(2015)
Eur J Pharm Biopharm
, vol.89
, pp. 312-328
-
-
Han, T.1
Das, D.B.2
-
36
-
-
75749124248
-
Topical delivery of active principles: The field of dermatological research
-
Nino M, Calabro G, Santoianni P. Topical delivery of active principles: the field of dermatological research. Dermatol Online J 2010; 16: 4
-
(2010)
Dermatol Online J
, vol.16
-
-
Nino, M.1
Calabro, G.2
Santoianni, P.3
-
37
-
-
0032470386
-
Acoustically active lipospheres containing paclitaxel: A new therapeutic ultrasound contrast agent
-
Unger EC, McCreery TP, Sweitzer RH, Caldwell VE, Wu Y. Acoustically active lipospheres containing paclitaxel: a new therapeutic ultrasound contrast agent. Invest Radiol 1998; 33: 88692
-
(1998)
Invest Radiol
, vol.33
, pp. 88692
-
-
Unger, E.C.1
McCreery, T.P.2
Sweitzer, R.H.3
Caldwell, V.E.4
Wu, Y.5
-
38
-
-
1942486333
-
Therapeutic applications of lipid-coated microbubbles
-
Unger EC, Porter T, Culp W, Labell R, Matsunaga T, Zutshi R. Therapeutic applications of lipid-coated microbubbles. Adv Drug Deliv Rev 2004; 56: 1291-314
-
(2004)
Adv Drug Deliv Rev
, vol.56
, pp. 1291-1314
-
-
Unger, E.C.1
Porter, T.2
Culp, W.3
Labell, R.4
Matsunaga, T.5
Zutshi, R.6
-
39
-
-
0042594669
-
Injectable microbubbles as contrast agents for diagnostic ultrasound imaging: The key role of perfluorochemicals
-
Schutt EG, Klein DH, Mattrey RM, Riess JG. Injectable microbubbles as contrast agents for diagnostic ultrasound imaging: the key role of perfluorochemicals. Angew Chem Int Ed Engl 2003; 42: 3218-35
-
(2003)
Angew Chem Int Ed Engl
, vol.42
, pp. 3218-3235
-
-
Schutt, E.G.1
Klein, D.H.2
Mattrey, R.M.3
Riess, J.G.4
-
40
-
-
0036664411
-
Contrast ultrasound targeted drug and gene delivery: An update on a new therapeutic modality
-
Price RJ, Kaul S. Contrast ultrasound targeted drug and gene delivery: an update on a new therapeutic modality. J Cardiovasc Pharmacol Ther 2002; 7: 171-80
-
(2002)
J Cardiovasc Pharmacol Ther
, vol.7
, pp. 171-180
-
-
Price, R.J.1
Kaul, S.2
-
42
-
-
0033978346
-
Enhanced cytotoxic effect of Ara-C by low intensity ultrasound to HL-60 cells
-
Tachibana K, Uchida T, Tamura K, Eguchi H, Yamashita N, Ogawa K. Enhanced cytotoxic effect of Ara-C by low intensity ultrasound to HL-60 cells. Cancer Lett 2000; 149: 189-94
-
(2000)
Cancer Lett
, vol.149
, pp. 189-194
-
-
Tachibana, K.1
Uchida, T.2
Tamura, K.3
Eguchi, H.4
Yamashita, N.5
Ogawa, K.6
-
43
-
-
0033064658
-
Micellar delivery of doxorubicin and its paramagnetic analog, ruboxyl, to HL-60 cells: Effect of micelle structure and ultrasound on the intracellular drug uptake
-
Rapoport NY, Herron JN, Pitt WG, Pitina L. Micellar delivery of doxorubicin and its paramagnetic analog, ruboxyl, to HL-60 cells: effect of micelle structure and ultrasound on the intracellular drug uptake. J Control Release 1999; 58: 153-62
-
(1999)
J Control Release
, vol.58
, pp. 153-162
-
-
Rapoport, N.Y.1
Herron, J.N.2
Pitt, W.G.3
Pitina, L.4
-
44
-
-
0030856769
-
Ultrasonic activated drug delivery from Pluronic P-105 micelles
-
Munshi N, Rapoport N, Pitt WG. Ultrasonic activated drug delivery from Pluronic P-105 micelles. Cancer Lett 1997; 118: 13-9
-
(1997)
Cancer Lett
, vol.118
, pp. 13-19
-
-
Munshi, N.1
Rapoport, N.2
Pitt, W.G.3
-
45
-
-
64649090846
-
Phase III study of gemcitabine plus docetaxel compared with capecitabine plus docetaxel for anthracycline-pretreated patients with metastatic breast cancer
-
Chan S, Romieu G, Huober J, et al. Phase III study of gemcitabine plus docetaxel compared with capecitabine plus docetaxel for anthracycline-pretreated patients with metastatic breast cancer. J Clin Oncol 2009; 27: 1753-60
-
(2009)
J Clin Oncol
, vol.27
, pp. 1753-1760
-
-
Chan, S.1
Romieu, G.2
Huober, J.3
-
46
-
-
0037066034
-
Local delivery of plasmid DNA into rat carotid artery using ultrasound
-
Taniyama Y, Tachibana K, Hiraoka K, et al. Local delivery of plasmid DNA into rat carotid artery using ultrasound. Circulation 2002; 105: 1233-9
-
(2002)
Circulation
, vol.105
, pp. 1233-1239
-
-
Taniyama, Y.1
Tachibana, K.2
Hiraoka, K.3
-
47
-
-
0038826285
-
Optimization of ultrasound parameters for cardiac gene delivery of adenoviral or plasmid deoxyribonucleic acid by ultrasound-targeted microbubble destruction
-
Chen S, Shohet RV, Bekeredjian R, Frenkel P, Grayburn PA. Optimization of ultrasound parameters for cardiac gene delivery of adenoviral or plasmid deoxyribonucleic acid by ultrasound-targeted microbubble destruction. J Am Coll Cardiol 2003; 42: 301-8
-
(2003)
J am Coll Cardiol
, vol.42
, pp. 301-308
-
-
Chen, S.1
Shohet, R.V.2
Bekeredjian, R.3
Frenkel, P.4
Grayburn, P.A.5
-
48
-
-
84895551360
-
Real-time, transcranial monitoring of safe blood-brain barrier opening in non-human primates
-
Marquet F, Teichert T, Wu SY, et al. Real-time, transcranial monitoring of safe blood-brain barrier opening in non-human primates. PLoS One 2014; 9: e84310
-
(2014)
Plos One
, vol.9
-
-
Marquet, F.1
Teichert, T.2
Wu, S.Y.3
-
49
-
-
84901589724
-
Ultrasoundmediated blood-brain barrier disruption for targeted drug delivery in the central nervous system
-
Aryal M, Arvanitis CD, Alexander PM, McDannold N. Ultrasoundmediated blood-brain barrier disruption for targeted drug delivery in the central nervous system. Adv Drug Deliv Rev 2014; 72: 94109
-
(2014)
Adv Drug Deliv Rev
, vol.72
-
-
Aryal, M.1
Arvanitis, C.D.2
Alexander, P.M.3
McDannold, N.4
-
50
-
-
84893564195
-
Mesenchymal stem cell transplantation enhancement in myocardial infarction rat model under ultrasound combined with nitric oxide microbubbles
-
Tong J, Ding J, Shen X, et al. Mesenchymal stem cell transplantation enhancement in myocardial infarction rat model under ultrasound combined with nitric oxide microbubbles. PLoS One 2013; 8: e80186
-
(2013)
Plos One
, vol.8
-
-
Tong, J.1
Ding, J.2
Shen, X.3
-
51
-
-
34447636787
-
Nanoparticle interaction with biological membranes: Does nanotechnology present a Janus face?
-
Leroueil PR, Hong S, Mecke A, Baker JR, Jr., Orr BG, Banaszak Holl MM. Nanoparticle interaction with biological membranes: does nanotechnology present a Janus face? Acc Chem Res 2007; 40: 335-42
-
(2007)
Acc Chem Res
, vol.40
, pp. 335-342
-
-
Leroueil, P.R.1
Hong, S.2
Mecke, A.3
Baker, J.R.4
Orr, B.G.5
Banaszak Holl, M.M.6
-
52
-
-
84938065842
-
Nanocarriers with tunable surface properties to unblock bottlenecks in systemic drug and gene delivery
-
Zou H, Wang Z, Feng M. Nanocarriers with tunable surface properties to unblock bottlenecks in systemic drug and gene delivery. J Control Release 2015; 214: 121-133
-
(2015)
J Control Release
, vol.214
, pp. 121-133
-
-
Zou, H.1
Wang, Z.2
Feng, M.3
-
53
-
-
52649120918
-
Functionalized-quantum-dot-liposome hybrids as multimodal nanoparticles for cancer
-
Al-Jamal WT, Al-Jamal KT, Bomans PH, Frederik PM, Kostarelos K. Functionalized-quantum-dot-liposome hybrids as multimodal nanoparticles for cancer. Small 2008; 4: 1406-15
-
(2008)
Small
, vol.4
, pp. 1406-1415
-
-
Al-Jamal, W.T.1
Al-Jamal, K.T.2
Bomans, P.H.3
Frederik, P.M.4
Kostarelos, K.5
-
54
-
-
84869232766
-
Realizing the clinical potential of cancer nanotechnology by minimizing toxicologic and targeted delivery concerns
-
Singh S, Sharma A, Robertson GP. Realizing the clinical potential of cancer nanotechnology by minimizing toxicologic and targeted delivery concerns. Cancer Res 2012; 72: 5663-8
-
(2012)
Cancer Res
, vol.72
, pp. 5663-5668
-
-
Singh, S.1
Sharma, A.2
Robertson, G.P.3
-
55
-
-
84947910789
-
Nanotechnology in Disease Diagnostic Techniques
-
Savaliya R, Shah D, Singh R, et al. Nanotechnology in Disease Diagnostic Techniques. Curr Drug Metab 2015; 16(8): 645-61
-
(2015)
Curr Drug Metab
, vol.16
, Issue.8
, pp. 645-661
-
-
Savaliya, R.1
Shah, D.2
Singh, R.3
-
56
-
-
84919468152
-
Layer-bylayer assembled milk protein coated magnetic nanoparticle enabled oral drug delivery with high stability in stomach and enzymeresponsive release in small intestine
-
Huang J, Shu Q, Wang L, Wu H, Wang AY, Mao H. Layer-bylayer assembled milk protein coated magnetic nanoparticle enabled oral drug delivery with high stability in stomach and enzymeresponsive release in small intestine. Biomaterials 2015; 39: 105-13
-
(2015)
Biomaterials
, vol.39
, pp. 105-113
-
-
Huang, J.1
Shu, Q.2
Wang, L.3
Wu, H.4
Wang, A.Y.5
Mao, H.6
-
57
-
-
79960258607
-
PHand sugar-sensitive layer-by-layer films and microcapsules for drug delivery
-
Sato K, Yoshida K, Takahashi S, Anzai J. pHand sugar-sensitive layer-by-layer films and microcapsules for drug delivery. Adv Drug Deliv Rev 2011; 63: 809-21
-
(2011)
Adv Drug Deliv Rev
, vol.63
, pp. 809-821
-
-
Sato, K.1
Yoshida, K.2
Takahashi, S.3
Anzai, J.4
-
58
-
-
84859326924
-
Sugar coated ceramic nanocarriers for the oral delivery of hydrophobic drugs: Formulation, optimization and evaluation
-
Kommineni S, Ahmad S, Vengala P, Subramanyam CV. Sugar coated ceramic nanocarriers for the oral delivery of hydrophobic drugs: formulation, optimization and evaluation. Drug Dev Ind Pharm 2012; 38: 577-86
-
(2012)
Drug Dev Ind Pharm
, vol.38
, pp. 577-586
-
-
Kommineni, S.1
Ahmad, S.2
Vengala, P.3
Subramanyam, C.V.4
-
59
-
-
84860764149
-
Low molecular-weight chitosan as a pH-sensitive stealth coating for tumor-specific drug delivery
-
Amoozgar Z, Park J, Lin Q, Yeo Y. Low molecular-weight chitosan as a pH-sensitive stealth coating for tumor-specific drug delivery. Mol Pharm 2012; 9: 1262-70
-
(2012)
Mol Pharm
, vol.9
, pp. 1262-1270
-
-
Amoozgar, Z.1
Park, J.2
Lin, Q.3
Yeo, Y.4
-
60
-
-
0842287342
-
Probing the Cytotoxicity of Semiconductor Quantum Dots
-
Derfus AM, Chan WCW, Bhatia SN. Probing the Cytotoxicity of Semiconductor Quantum Dots. Nano Lett 2004; 4: 11-18
-
(2004)
Nano Lett
, vol.4
, pp. 11-18
-
-
Derfus, A.M.1
Chan, W.2
Bhatia, S.N.3
-
62
-
-
55349083664
-
Lipid-gold-nanoparticle hybrid-based gene delivery
-
Rhim WK, Kim JS, Nam JM. Lipid-gold-nanoparticle hybrid-based gene delivery. Small 2008; 4: 1651-5
-
(2008)
Small
, vol.4
, pp. 1651-1655
-
-
Rhim, W.K.1
Kim, J.S.2
Nam, J.M.3
-
63
-
-
84864184410
-
Organelle-specific detection of phosphatase activities with two-photon fluorogenic probes in cells and tissues
-
Li L, Ge J, Wu H, Xu QH, Yao SQ. Organelle-specific detection of phosphatase activities with two-photon fluorogenic probes in cells and tissues. J Am Chem Soc 2012; 134: 12157-67
-
(2012)
J am Chem Soc
, vol.134
, pp. 12157-12167
-
-
Li, L.1
Ge, J.2
Wu, H.3
Xu, Q.H.4
Yao, S.Q.5
-
64
-
-
84864125045
-
Peptides as targeting elements and tissue penetration devices for nanoparticles
-
Ruoslahti E. Peptides as targeting elements and tissue penetration devices for nanoparticles. Adv Mater 2012; 24: 3747-56
-
(2012)
Adv Mater
, vol.24
, pp. 3747-3756
-
-
Ruoslahti, E.1
-
65
-
-
84896914760
-
Cell-penetrating peptides: Design, synthesis, and applications
-
Copolovici DM, Langel K, Eriste E, Langel U. Cell-penetrating peptides: design, synthesis, and applications. ACS Nano 2014; 8: 1972-94
-
(2014)
ACS Nano
, vol.8
, pp. 1972-1994
-
-
Copolovici, D.M.1
Langel, K.2
Eriste, E.3
Langel, U.4
-
66
-
-
1542721107
-
Cell penetrating peptides in drug delivery
-
Snyder EL, Dowdy SF. Cell penetrating peptides in drug delivery. Pharm Res 2004; 21: 389-93
-
(2004)
Pharm Res
, vol.21
, pp. 389-393
-
-
Snyder, E.L.1
Dowdy, S.F.2
-
67
-
-
38949192863
-
Tat peptide-mediated intracellular delivery of pharmaceutical nanocarriers
-
Torchilin VP. Tat peptide-mediated intracellular delivery of pharmaceutical nanocarriers. Adv Drug Deliv Rev 2008; 60: 548-58
-
(2008)
Adv Drug Deliv Rev
, vol.60
, pp. 548-558
-
-
Torchilin, V.P.1
-
68
-
-
33947426789
-
Cell-penetrating quantum dots based on multivalent and endosome-disrupting surface coatings
-
Duan H, Nie S. Cell-penetrating quantum dots based on multivalent and endosome-disrupting surface coatings. J Am Chem Soc 2007; 129: 3333-8
-
(2007)
J am Chem Soc
, vol.129
, pp. 3333-3338
-
-
Duan, H.1
Nie, S.2
-
69
-
-
34249673425
-
Plasmonic nanosensors for imaging intracellular biomarkers in live cells
-
Kumar S, Harrison N, Richards-Kortum R, Sokolov K. Plasmonic nanosensors for imaging intracellular biomarkers in live cells. Nano Lett 2007; 7: 1338-43
-
(2007)
Nano Lett
, vol.7
, pp. 1338-1343
-
-
Kumar, S.1
Harrison, N.2
Richards-Kortum, R.3
Sokolov, K.4
-
70
-
-
84872561067
-
Acid-active cell-penetrating peptides for in vivo tumor-targeted drug delivery
-
Jin E, Zhang B, Sun X, et al. Acid-active cell-penetrating peptides for in vivo tumor-targeted drug delivery. J Am Chem Soc 2013; 135: 933-40
-
(2013)
J am Chem Soc
, vol.135
, pp. 933-940
-
-
Jin, E.1
Zhang, B.2
Sun, X.3
-
71
-
-
0343882023
-
Targeted drug delivery via the folate receptor
-
Sudimack J, Lee RJ. Targeted drug delivery via the folate receptor. Adv Drug Deliv Rev 2000; 41: 147-62
-
(2000)
Adv Drug Deliv Rev
, vol.41
, pp. 147-162
-
-
Sudimack, J.1
Lee, R.J.2
-
72
-
-
34547171711
-
Dendrimer-entrapped gold nanoparticles as a platform for cancer-cell targeting and imaging
-
Shi X, Wang S, Meshinchi S, et al. Dendrimer-entrapped gold nanoparticles as a platform for cancer-cell targeting and imaging. Small 2007; 3: 1245-52
-
(2007)
Small
, vol.3
, pp. 1245-1252
-
-
Shi, X.1
Wang, S.2
Meshinchi, S.3
-
73
-
-
25844461769
-
Target-specific cellular uptake of PLGA nanoparticles coated with poly(L-lysine)poly(ethylene glycol)-folate conjugate
-
Kim SH, Jeong JH, Chun KW, Park TG. Target-specific cellular uptake of PLGA nanoparticles coated with poly(L-lysine)poly(ethylene glycol)-folate conjugate. Langmuir 2005; 21: 8852-7
-
(2005)
Langmuir
, vol.21
, pp. 8852-8857
-
-
Kim, S.H.1
Jeong, J.H.2
Chun, K.W.3
Park, T.G.4
-
74
-
-
33646920343
-
Synthesis and grafting of thioctic acid-PEG-folate conjugates onto Au nanoparticles for selective targeting of folate receptorpositive tumor cells
-
Dixit V, Van den Bossche J, Sherman DM, Thompson DH, Andres RP. Synthesis and grafting of thioctic acid-PEG-folate conjugates onto Au nanoparticles for selective targeting of folate receptorpositive tumor cells. Bioconjug Chem 2006; 17: 603-9
-
(2006)
Bioconjug Chem
, vol.17
, pp. 603-609
-
-
Dixit, V.1
Van Den Bossche, J.2
Sherman, D.M.3
Thompson, D.H.4
Res, R.P.5
-
75
-
-
34548240631
-
Attaching folic acid on gold nanoparticles using noncovalent interaction via different polyethylene glycol backbones and targeting of cancer cells
-
Bhattacharya R, Patra CR, Earl A, et al. Attaching folic acid on gold nanoparticles using noncovalent interaction via different polyethylene glycol backbones and targeting of cancer cells. Nanomedicine: Nanotechnol Biol Med 2007; 3: 224-38
-
(2007)
Nanomedicine: Nanotechnol Biol Med
, vol.3
, pp. 224-238
-
-
Bhattacharya, R.1
Patra, C.R.2
Earl, A.3
-
76
-
-
0036889760
-
Targeted drug delivery via the transferrin receptor-mediated endocytosis pathway
-
Qian ZM, Li H, Sun H, Ho K. Targeted drug delivery via the transferrin receptor-mediated endocytosis pathway. Pharmacol Rev 2002; 54: 561-87
-
(2002)
Pharmacol Rev
, vol.54
, pp. 561-587
-
-
Qian, Z.M.1
Li, H.2
Sun, H.3
Ho, K.4
-
77
-
-
83355177979
-
Anti-tumor activity of paclitaxel through dual-targeting carrier of cyclic RGD and transferrin conjugated hyperbranched copolymer nanoparticles
-
Xu Q, Liu Y, Su S, Li W, Chen C, Wu Y. Anti-tumor activity of paclitaxel through dual-targeting carrier of cyclic RGD and transferrin conjugated hyperbranched copolymer nanoparticles. Biomaterials 2012; 33: 1627-39
-
(2012)
Biomaterials
, vol.33
, pp. 1627-1639
-
-
Xu, Q.1
Liu, Y.2
Su, S.3
Li, W.4
Chen, C.5
Wu, Y.6
-
78
-
-
0025074907
-
In vitro selection of RNA molecules that bind specific ligands
-
Ellington AD, Szostak JW. In vitro selection of RNA molecules that bind specific ligands. Nature 1990; 346: 818-22
-
(1990)
Nature
, vol.346
, pp. 818-822
-
-
Ellington, A.D.1
Szostak, J.W.2
-
79
-
-
84905643347
-
Progress in selection and biomedical applications of aptamers
-
Xi Z, Huang R, Deng Y, He N. Progress in selection and biomedical applications of aptamers. J Biomed Nanotechnol 2014; 10: 3043-62
-
(2014)
J Biomed Nanotechnol
, vol.10
, pp. 3043-3062
-
-
Xi, Z.1
Huang, R.2
Deng, Y.3
He, N.4
-
80
-
-
74049133619
-
Subcellular targeting strategies for drug design and delivery
-
Rajendran L, Knolker HJ, Simons K. Subcellular targeting strategies for drug design and delivery. Nat Rev Drug Discov 2010; 9: 29-42
-
(2010)
Nat Rev Drug Discov
, vol.9
, pp. 29-42
-
-
Rajendran, L.1
Knolker, H.J.2
Simons, K.3
-
81
-
-
84927923698
-
Dual drug conjugated nanoparticle for simultaneous targeting of mitochondria and nucleus in cancer cells
-
Mallick A, More P, Ghosh S, et al. Dual drug conjugated nanoparticle for simultaneous targeting of mitochondria and nucleus in cancer cells. ACS Appl Mater Interfaces 2015; 7: 7584-98
-
(2015)
ACS Appl Mater Interfaces
, vol.7
, pp. 7584-7598
-
-
Mallick, A.1
More, P.2
Ghosh, S.3
-
82
-
-
78650954706
-
Improving drug potency and efficacy by nanocarrier-mediated subcellular targeting
-
64ra2
-
Murakami M, Cabral H, Matsumoto Y, et al. Improving drug potency and efficacy by nanocarrier-mediated subcellular targeting. Sci Transl Med 2011; 3: 64ra2
-
(2011)
Sci Transl Med
, vol.3
-
-
Murakami, M.1
Cabral, H.2
Matsumoto, Y.3
-
83
-
-
84902477538
-
Thermo-triggered drug release from actively targeting polymer micelles
-
Guo X, Li D, Yang G, et al. Thermo-triggered drug release from actively targeting polymer micelles. ACS Appl Mater Interfaces 2014; 6: 8549-59
-
(2014)
ACS Appl Mater Interfaces
, vol.6
, pp. 8549-8559
-
-
Guo, X.1
Li, D.2
Yang, G.3
-
84
-
-
84893816633
-
Biodegradable polymeric vesicles containing magnetic nanoparticles, quantum dots and anticancer drugs for drug delivery and imaging
-
Ye F, Barrefelt A, Asem H, et al. Biodegradable polymeric vesicles containing magnetic nanoparticles, quantum dots and anticancer drugs for drug delivery and imaging. Biomaterials 2014; 35: 3885-94
-
(2014)
Biomaterials
, vol.35
, pp. 3885-3894
-
-
Ye, F.1
Barrefelt, A.2
Asem, H.3
-
85
-
-
0036707316
-
Biodegradable nanoparticles for drug delivery and targeting
-
Hans ML, Lowman AM. Biodegradable nanoparticles for drug delivery and targeting. Curr Opin Solid State Mater Sci 2002; 6: 319-27
-
(2002)
Curr Opin Solid State Mater Sci
, vol.6
, pp. 319-327
-
-
Hans, M.L.1
Lowman, A.M.2
-
86
-
-
84890130882
-
Stimuli-responsive biodegradable poly(Methacrylic acid) based nanocapsules for ultrasound traced and triggered drug delivery system
-
Yang P, Li D, Jin S, et al. Stimuli-responsive biodegradable poly(methacrylic acid) based nanocapsules for ultrasound traced and triggered drug delivery system. Biomaterials 2014; 35: 2079-88
-
(2014)
Biomaterials
, vol.35
, pp. 2079-2088
-
-
Yang, P.1
Li, D.2
Jin, S.3
-
87
-
-
84923224644
-
Biodegradable tetraPEG hydrogels as carriers for a releasable drug delivery system
-
Henise J, Hearn BR, Ashley GW, Santi DV. Biodegradable tetraPEG hydrogels as carriers for a releasable drug delivery system. Bioconjug Chem 2015; 26: 270-8
-
(2015)
Bioconjug Chem
, vol.26
, pp. 270-278
-
-
Henise, J.1
Hearn, B.R.2
Ashley, G.W.3
Santi, D.V.4
-
88
-
-
77954277190
-
Economic evaluation of zoledronic acid for the prevention of osteoporotic fractures in postmenopausal women with early-stage breast cancer receiving aromatase inhibitors in the UK
-
Logman JF, Heeg BM, Botteman MF, Kaura S, van Hout BA. Economic evaluation of zoledronic acid for the prevention of osteoporotic fractures in postmenopausal women with early-stage breast cancer receiving aromatase inhibitors in the UK. Ann Oncol 2010; 21: 1529-36
-
(2010)
Ann Oncol
, vol.21
, pp. 1529-1536
-
-
Logman, J.F.1
Heeg, B.M.2
Botteman, M.F.3
Kaura, S.4
Van Hout, B.A.5
-
89
-
-
80052386569
-
Enhanced anti-tumor efficacy by co-delivery of doxorubicin and paclitaxel with amphiphilic methoxy PEG-PLGA copolymer nanoparticles
-
Wang H, Zhao Y, Wu Y, et al. Enhanced anti-tumor efficacy by co-delivery of doxorubicin and paclitaxel with amphiphilic methoxy PEG-PLGA copolymer nanoparticles. Biomaterials 2011; 32: 8281-90
-
(2011)
Biomaterials
, vol.32
, pp. 8281-8290
-
-
Wang, H.1
Zhao, Y.2
Wu, Y.3
-
90
-
-
57649124218
-
The codelivery of paclitaxel and Herceptin using cationic micellar nanoparticles
-
Lee AL, Wang Y, Cheng HY, Pervaiz S, Yang YY. The codelivery of paclitaxel and Herceptin using cationic micellar nanoparticles. Biomaterials 2009; 30: 919-27
-
(2009)
Biomaterials
, vol.30
, pp. 919-927
-
-
Lee, A.L.1
Wang, Y.2
Cheng, H.Y.3
Pervaiz, S.4
Yang, Y.Y.5
-
91
-
-
41049096756
-
Effect of the ABCB1 modulators elacridar and tariquidar on the distribution of paclitaxel in nude mice
-
Hubensack M, Muller C, Hocherl P, et al. Effect of the ABCB1 modulators elacridar and tariquidar on the distribution of paclitaxel in nude mice. J Cancer Res Clin Oncol 2008; 134: 597-607
-
(2008)
J Cancer Res Clin Oncol
, vol.134
, pp. 597-607
-
-
Hubensack, M.1
Muller, C.2
Hocherl, P.3
-
92
-
-
67349183943
-
A phase I trial of continuous infusion of the multidrug resistance inhibitor zosuquidar with daunorubicin and cytarabine in acute myeloid leukemia
-
Lancet JE, Baer MR, Duran GE, et al. A phase I trial of continuous infusion of the multidrug resistance inhibitor zosuquidar with daunorubicin and cytarabine in acute myeloid leukemia. Leuk Res 2009; 33: 1055-61
-
(2009)
Leuk Res
, vol.33
, pp. 1055-1061
-
-
Lancet, J.E.1
Baer, M.R.2
Duran, G.E.3
-
93
-
-
84881502609
-
Nanomaterials as non-viral siRNA delivery agents for cancer therapy
-
Singh S. Nanomaterials as non-viral siRNA delivery agents for cancer therapy. Bioimpacts 2013; 3: 53-65
-
(2013)
Bioimpacts
, vol.3
, pp. 53-65
-
-
Singh, S.1
-
94
-
-
84856431819
-
RNA therapeutics: Beyond RNA interference and antisense oligonucleotides
-
Kole R, Krainer AR, Altman S. RNA therapeutics: beyond RNA interference and antisense oligonucleotides. Nat Rev Drug Discov 2012; 11: 125-40
-
(2012)
Nat Rev Drug Discov
, vol.11
, pp. 125-140
-
-
Kole, R.1
Krainer, A.R.2
Altman, S.3
-
95
-
-
84879667833
-
MiR-29 targets Akt3 to reduce proliferation and facilitate differentiation of myoblasts in skeletal muscle development
-
Wei W, He HB, Zhang WY, et al. miR-29 targets Akt3 to reduce proliferation and facilitate differentiation of myoblasts in skeletal muscle development. Cell Death Dis 2013; 4: e668
-
(2013)
Cell Death Dis
, vol.4
-
-
Wei, W.1
He, H.B.2
Zhang, W.Y.3
-
96
-
-
84902265135
-
Knockdown of AKT3 (PKBgamma) and PI3KCA suppresses cell viability and proliferation and induces the apoptosis of glioblastoma multiforme T98G cells
-
Paul-Samojedny M, Suchanek R, Borkowska P, et al. Knockdown of AKT3 (PKBgamma) and PI3KCA suppresses cell viability and proliferation and induces the apoptosis of glioblastoma multiforme T98G cells. Biomed Res Int 2014; 2014: 768-181
-
(2014)
Biomed Res Int
, vol.2014
, pp. 181-768
-
-
Paul-Samojedny, M.1
Suchanek, R.2
Borkowska, P.3
-
97
-
-
54849373400
-
Targeting V600EB-Raf and Akt3 using nanoliposomal-small interfering RNA inhibits cutaneous melanocytic lesion development
-
Tran MA, Gowda R, Sharma A, et al. Targeting V600EB-Raf and Akt3 using nanoliposomal-small interfering RNA inhibits cutaneous melanocytic lesion development. Cancer Res 2008; 68: 7638-49
-
(2008)
Cancer Res
, vol.68
, pp. 7638-7649
-
-
Tran, M.A.1
Gowda, R.2
Sharma, A.3
-
98
-
-
0032506125
-
Genetic instability of cancer cells is proportional to their degree of aneuploidy
-
Duesberg P, Rausch C, Rasnick D, Hehlmann R. Genetic instability of cancer cells is proportional to their degree of aneuploidy. Proc Natl Acad Sci USA 1998; 95: 13692-7
-
(1998)
Proc Natl Acad Sci USA
, vol.95
, pp. 13692-13697
-
-
Duesberg, P.1
Rausch, C.2
Rasnick, D.3
Hehlmann, R.4
-
99
-
-
64249107600
-
Self-assembled oligopeptide nanostructures for co-delivery of drug and gene with synergistic therapeutic effect
-
Wiradharma N, Tong YW, Yang YY. Self-assembled oligopeptide nanostructures for co-delivery of drug and gene with synergistic therapeutic effect. Biomaterials 2009; 30: 3100-9
-
(2009)
Biomaterials
, vol.30
, pp. 3100-3109
-
-
Wiradharma, N.1
Tong, Y.W.2
Yang, Y.Y.3
-
100
-
-
68549109372
-
Targeted intracellular codelivery of chemotherapeutics and nucleic acid with a well-defined dendrimerbased nanoglobular carrier
-
Kaneshiro TL, Lu ZR. Targeted intracellular codelivery of chemotherapeutics and nucleic acid with a well-defined dendrimerbased nanoglobular carrier. Biomaterials 2009; 30: 5660-6
-
(2009)
Biomaterials
, vol.30
, pp. 5660-5666
-
-
Kaneshiro, T.L.1
Lu, Z.R.2
-
101
-
-
77749279909
-
Co-delivery of as-miR-21 and 5FU by poly(Amidoamine) dendrimer attenuates human glioma cell growth in vitro
-
Ren Y, Kang CS, Yuan XB, et al. Co-delivery of as-miR-21 and 5FU by poly(amidoamine) dendrimer attenuates human glioma cell growth in vitro. J Biomater Sci Polym Ed 2010; 21: 303-14
-
(2010)
J Biomater Sci Polym Ed
, vol.21
, pp. 303-314
-
-
Ren, Y.1
Kang, C.S.2
Yuan, X.B.3
-
102
-
-
70350707597
-
The use of nanoparticle-mediated targeted gene silencing and drug delivery to overcome tumor drug resistance
-
Patil YB, Swaminathan SK, Sadhukha T, Ma L, Panyam J. The use of nanoparticle-mediated targeted gene silencing and drug delivery to overcome tumor drug resistance. Biomaterials 2010; 31: 358-65
-
(2010)
Biomaterials
, vol.31
, pp. 358-365
-
-
Patil, Y.B.1
Swaminathan, S.K.2
Sadhukha, T.3
Ma, L.4
Panyam, J.5
-
103
-
-
84891372908
-
Star-branched amphiphilic PLA-bPDMAEMA copolymers for co-delivery of miR-21 inhibitor and doxorubicin to treat glioma
-
Qian X, Long L, Shi Z, et al. Star-branched amphiphilic PLA-bPDMAEMA copolymers for co-delivery of miR-21 inhibitor and doxorubicin to treat glioma. Biomaterials 2014; 35: 2322-35
-
(2014)
Biomaterials
, vol.35
, pp. 2322-2335
-
-
Qian, X.1
Long, L.2
Shi, Z.3
-
104
-
-
34447298630
-
Targeted charge-reversal nanoparticles for nuclear drug delivery
-
Xu P, Van Kirk EA, Zhan Y, Murdoch WJ, Radosz M, Shen Y. Targeted charge-reversal nanoparticles for nuclear drug delivery. Angew Chem Int Ed Engl 2007; 46: 4999-5002
-
(2007)
Angew Chem Int Ed Engl
, vol.46
, pp. 4999-5002
-
-
Xu, P.1
Van Kirk, E.A.2
Zhan, Y.3
Murdoch, W.J.4
Radosz, M.5
Shen, Y.6
-
105
-
-
33747877757
-
In vitro and in vivo intracellular liposomal delivery of antisense oligonucleotides and anticancer drug
-
Pakunlu RI, Wang Y, Saad M, Khandare JJ, Starovoytov V, Minko T. In vitro and in vivo intracellular liposomal delivery of antisense oligonucleotides and anticancer drug. J Control Release 2006; 114: 153-62
-
(2006)
J Control Release
, vol.114
, pp. 153-162
-
-
Pakunlu, R.I.1
Wang, Y.2
Saad, M.3
Khandare, J.J.4
Starovoytov, V.5
Minko, T.6
-
106
-
-
0035877967
-
Mitochondria-targeting drugs arsenic trioxide and lonidamine bypass the resistance of TPAdifferentiated leukemic cells to apoptosis
-
Sordet O, Rebe C, Leroy I, et al. Mitochondria-targeting drugs arsenic trioxide and lonidamine bypass the resistance of TPAdifferentiated leukemic cells to apoptosis. Blood 2001; 97: 393-140
-
(2001)
Blood
, vol.97
, pp. 140-393
-
-
Sordet, O.1
Rebe, C.2
Leroy, I.3
-
107
-
-
0034871056
-
Apoptosis and mitochondrial damage in INS-1 cells treated with alloxan
-
Sakurai K, Katoh M, Someno K, Fujimoto Y. Apoptosis and mitochondrial damage in INS-1 cells treated with alloxan. Biol Pharm Bull 2001; 24: 876-82
-
(2001)
Biol Pharm Bull
, vol.24
, pp. 876-882
-
-
Sakurai, K.1
Katoh, M.2
Someno, K.3
Fujimoto, Y.4
-
108
-
-
77957554723
-
Preclinical characterization of mitochondria-targeted small molecule hsp90 inhibitors, gamitrinibs, in advanced prostate cancer
-
Kang BH, Siegelin MD, Plescia J, et al. Preclinical characterization of mitochondria-targeted small molecule hsp90 inhibitors, gamitrinibs, in advanced prostate cancer. Clin Cancer Res 2010; 16: 4779-88
-
(2010)
Clin Cancer Res
, vol.16
, pp. 4779-4788
-
-
Kang, B.H.1
Siegelin, M.D.2
Plescia, J.3
-
109
-
-
84870354356
-
PH-sensitive poly(Histidine)PEG/DSPE-PEG co-polymer micelles for cytosolic drug delivery
-
Wu H, Zhu L, Torchilin VP. pH-sensitive poly(histidine)PEG/DSPE-PEG co-polymer micelles for cytosolic drug delivery. Biomaterials 2013; 34: 1213-22
-
(2013)
Biomaterials
, vol.34
, pp. 1213-1222
-
-
Wu, H.1
Zhu, L.2
Torchilin, V.P.3
-
110
-
-
84865762982
-
Poly(Styrene-co-maleic acid)-based pH-sensitive liposomes mediate cytosolic delivery of drugs for enhanced cancer chemotherapy
-
Banerjee S, Sen K, Pal TK, Guha SK. Poly(styrene-co-maleic acid)-based pH-sensitive liposomes mediate cytosolic delivery of drugs for enhanced cancer chemotherapy. Int J Pharm 2012; 436: 786-97
-
(2012)
Int J Pharm
, vol.436
, pp. 786-797
-
-
Banerjee, S.1
Sen, K.2
Pal, T.K.3
Guha, S.K.4
-
111
-
-
84905757850
-
A lysosome-targeted drug delivery system based on sorbitol backbone towards efficient cancer therapy
-
Maniganda S, Sankar V, Nair JB, Raghu KG, Maiti KK. A lysosome-targeted drug delivery system based on sorbitol backbone towards efficient cancer therapy. Org Biomol Chem 2014; 12: 6564-9
-
(2014)
Org Biomol Chem
, vol.12
, pp. 6564-6569
-
-
Maniganda, S.1
Sankar, V.2
Nair, J.B.3
Raghu, K.G.4
Maiti, K.K.5
-
112
-
-
79955801224
-
Efficient chemotherapy of rat glioblastoma using doxorubicin-loaded PLGA nanoparticles with different stabilizers
-
Wohlfart S, Khalansky AS, Gelperina S, et al. Efficient chemotherapy of rat glioblastoma using doxorubicin-loaded PLGA nanoparticles with different stabilizers. PLoS One 2011; 6: e19121
-
(2011)
Plos One
, vol.6
-
-
Wohlfart, S.1
Khalansky, A.S.2
Gelperina, S.3
-
113
-
-
84878614148
-
Cholic acidfunctionalized nanoparticles of star-shaped PLGA-vitamin E TPGS copolymer for docetaxel delivery to cervical cancer
-
Zeng X, Tao W, Mei L, Huang L, Tan C, Feng SS. Cholic acidfunctionalized nanoparticles of star-shaped PLGA-vitamin E TPGS copolymer for docetaxel delivery to cervical cancer. Biomaterials 2013; 34: 6058-67
-
(2013)
Biomaterials
, vol.34
, pp. 6058-6067
-
-
Zeng, X.1
Tao, W.2
Mei, L.3
Huang, L.4
Tan, C.5
Feng, S.S.6
-
114
-
-
58749106812
-
Brain transport of neurotoxin-I with PLA nanoparticles through intranasal administration in rats: A microdialysis study
-
Cheng Q, Feng J, Chen J, Zhu X, Li F. Brain transport of neurotoxin-I with PLA nanoparticles through intranasal administration in rats: a microdialysis study. Biopharm Drug Dispos 2008; 29: 431-9
-
(2008)
Biopharm Drug Dispos
, vol.29
, pp. 431-439
-
-
Cheng, Q.1
Feng, J.2
Chen, J.3
Zhu, X.4
Li, F.5
-
115
-
-
33750620330
-
Intracellular delivery of saquinavir in biodegradable polymeric nanoparticles for HIV/AIDS
-
Shah LK, Amiji MM. Intracellular delivery of saquinavir in biodegradable polymeric nanoparticles for HIV/AIDS. Pharm Res 2006; 23: 2638-45
-
(2006)
Pharm Res
, vol.23
, pp. 2638-2645
-
-
Shah, L.K.1
Amiji, M.M.2
-
116
-
-
79955104821
-
Angiopep-conjugated poly(Ethylene glycol)-co-poly(epsilon-caprolactone) nanoparticles as dualtargeting drug delivery system for brain glioma
-
Xin H, Jiang X, Gu J, et al. Angiopep-conjugated poly(ethylene glycol)-co-poly(epsilon-caprolactone) nanoparticles as dualtargeting drug delivery system for brain glioma. Biomaterials 2011; 32: 4293-305
-
(2011)
Biomaterials
, vol.32
, pp. 4293-4305
-
-
Xin, H.1
Jiang, X.2
Gu, J.3
-
117
-
-
67651230648
-
Study on docetaxelloaded nanoparticles with high antitumor efficacy against malignant melanoma
-
Zheng D, Li X, Xu H, Lu X, Hu Y, Fan W. Study on docetaxelloaded nanoparticles with high antitumor efficacy against malignant melanoma. Acta Biochim Biophys Sin (Shanghai) 2009; 41: 578-87
-
(2009)
Acta Biochim Biophys Sin (Shanghai)
, vol.41
, pp. 578-587
-
-
Zheng, D.1
Li, X.2
Xu, H.3
Lu, X.4
Hu, Y.5
Fan, W.6
-
118
-
-
68249152032
-
Preparation, characterization, in-vitro drug release and cellular uptake of poly(Caprolactone) grafted dextran copolymeric nanoparticles loaded with anticancer drug
-
Prabu P, Chaudhari AA, Dharmaraj N, Khil MS, Park SY, Kim HY. Preparation, characterization, in-vitro drug release and cellular uptake of poly(caprolactone) grafted dextran copolymeric nanoparticles loaded with anticancer drug. J Biomed Mater Res A 2009; 90: 1128-36
-
(2009)
J Biomed Mater Res A
, vol.90
, pp. 1128-1136
-
-
Prabu, P.1
Chaudhari, A.A.2
Dharmaraj, N.3
Khil, M.S.4
Park, S.Y.5
Kim, H.Y.6
-
119
-
-
35848959714
-
Alginate/chitosan nanoparticles are effective for oral insulin delivery
-
Sarmento B, Ribeiro A, Veiga F, Sampaio P, Neufeld R, Ferreira D. Alginate/chitosan nanoparticles are effective for oral insulin delivery. Pharm Res 2007; 24: 2198-206
-
(2007)
Pharm Res
, vol.24
, pp. 2198-2206
-
-
Sarmento, B.1
Ribeiro, A.2
Veiga, F.3
Sampaio, P.4
Neufeld, R.5
Ferreira, D.6
-
120
-
-
79955960211
-
Composite polymeric magnetic nanoparticles for codelivery of hydrophobic and hydrophilic anticancer drugs and MRI imaging for cancer therapy
-
Singh A, Dilnawaz F, Mewar S, Sharma U, Jagannathan NR, Sahoo SK. Composite polymeric magnetic nanoparticles for codelivery of hydrophobic and hydrophilic anticancer drugs and MRI imaging for cancer therapy. ACS Appl Mater Interfaces 2011; 3: 842-56
-
(2011)
ACS Appl Mater Interfaces
, vol.3
, pp. 842-856
-
-
Singh, A.1
Dilnawaz, F.2
Mewar, S.3
Sharma, U.4
Jagannathan, N.R.5
Sahoo, S.K.6
-
121
-
-
77649121111
-
Functional graphene oxide as a nanocarrier for controlled loading and targeted delivery of mixed anticancer drugs
-
Zhang L, Xia J, Zhao Q, Liu L, Zhang Z. Functional graphene oxide as a nanocarrier for controlled loading and targeted delivery of mixed anticancer drugs. Small 2010; 6: 537-44
-
(2010)
Small
, vol.6
, pp. 537-544
-
-
Zhang, L.1
Xia, J.2
Zhao, Q.3
Liu, L.4
Zhang, Z.5
-
122
-
-
0037110625
-
A Phase II trial of pegylated liposomal doxorubicin, vincristine, and reduced-dose dexamethasone combination therapy in newly diagnosed multiple myeloma patients
-
Hussein MA, Wood L, Hsi E, et al. A Phase II trial of pegylated liposomal doxorubicin, vincristine, and reduced-dose dexamethasone combination therapy in newly diagnosed multiple myeloma patients. Cancer 2002; 95: 2160-8
-
(2002)
Cancer
, vol.95
, pp. 2160-2168
-
-
Hussein, M.A.1
Wood, L.2
Hsi, E.3
-
123
-
-
84894468804
-
Self-assembled hybrid nanoparticles for targeted co-delivery of two drugs into cancer cells
-
Huang F, You M, Chen T, Zhu G, Liang H, Tan W. Self-assembled hybrid nanoparticles for targeted co-delivery of two drugs into cancer cells. Chem Commun (Camb) 2014; 50: 3103-5
-
(2014)
Chem Commun (Camb)
, vol.50
, pp. 3103-3105
-
-
Huang, F.1
You, M.2
Chen, T.3
Zhu, G.4
Liang, H.5
Tan, W.6
-
124
-
-
78651225870
-
Parathyroid hormone (1-34)-coated microneedle patch system: Clinical pharmacokinetics and pharmacodynamics for treatment of osteoporosis
-
Daddona PE, Matriano JA, Mandema J, Maa YF. Parathyroid hormone (1-34)-coated microneedle patch system: clinical pharmacokinetics and pharmacodynamics for treatment of osteoporosis. Pharm Res 2011; 28: 159-65
-
(2011)
Pharm Res
, vol.28
, pp. 159-165
-
-
Daddona, P.E.1
Matriano, J.A.2
Mandema, J.3
Maa, Y.F.4
-
125
-
-
58049200809
-
Phase I trial of interleukin-12 plasmid electroporation in patients with metastatic melanoma
-
Daud AI, DeConti RC, Andrews S, et al. Phase I trial of interleukin-12 plasmid electroporation in patients with metastatic melanoma. J Clin Oncol 2008; 26: 5896-903
-
(2008)
J Clin Oncol
, vol.26
, pp. 5896-5903
-
-
Daud, A.I.1
Deconti, R.C.2
Rews, S.3
-
126
-
-
79953749889
-
Relationship between urinary sodium excretion and pioglitazone-induced edema
-
Nakamura A, Osonoi T, Terauchi Y. Relationship between urinary sodium excretion and pioglitazone-induced edema. J Diabetes Investig 2010; 1: 208-11
-
(2010)
J Diabetes Investig
, vol.1
, pp. 208-211
-
-
Nakamura, A.1
Osonoi, T.2
Terauchi, Y.3
-
127
-
-
79952197781
-
Nonclinical and clinical experiences with CPP-based self-assembling peptide systems in topical drug development
-
Waugh JM, Lee J, Dake MD, Browne D. Nonclinical and clinical experiences with CPP-based self-assembling peptide systems in topical drug development. Methods Mol Biol 2011; 683: 553-72
-
(2011)
Methods Mol Biol
, vol.683
, pp. 553-572
-
-
Waugh, J.M.1
Lee, J.2
Dake, M.D.3
Browne, D.4
-
128
-
-
10844293438
-
Phase I clinical trial and pharmacokinetic evaluation of NK911, a micelle-encapsulated doxorubicin
-
Matsumura Y, Hamaguchi T, Ura T, et al. Phase I clinical trial and pharmacokinetic evaluation of NK911, a micelle-encapsulated doxorubicin. Br J Cancer 2004; 91: 1775-81
-
(2004)
Br J Cancer
, vol.91
, pp. 1775-1781
-
-
Matsumura, Y.1
Hamaguchi, T.2
Ura, T.3
-
129
-
-
84858665432
-
Preclinical development and clinical translation of a PSMA-targeted docetaxel nanoparticle with a differentiated pharmacological profile
-
128ra39
-
Hrkach J, Von Hoff D, Mukkaram Ali M, et al. Preclinical development and clinical translation of a PSMA-targeted docetaxel nanoparticle with a differentiated pharmacological profile. Sci Transl Med 2012; 4: 128ra39
-
(2012)
Sci Transl Med
, vol.4
-
-
Hrkach, J.1
Von Hoff, D.2
Mukkaram Ali, M.3
-
130
-
-
0037096755
-
Superior survival with capecitabine plus docetaxel combination therapy in anthracyclinepretreated patients with advanced breast cancer: Phase III trial results
-
O'Shaughnessy J, Miles D, Vukelja S. Superior survival with capecitabine plus docetaxel combination therapy in anthracyclinepretreated patients with advanced breast cancer: phase III trial results. J Clin Oncol 2002; 20(12): 2812-23
-
(2002)
J Clin Oncol
, vol.20
, Issue.12
, pp. 2812-2823
-
-
O'shaughnessy, J.1
Miles, D.2
Vukelja, S.3
-
131
-
-
80455174632
-
A double-modulation strategy in cancer treatment with a chemotherapeutic agent and siRNA
-
Nakamura K, Abu Lila AS, Matsunaga M, Doi Y, Ishida T, Kiwada H. A double-modulation strategy in cancer treatment with a chemotherapeutic agent and siRNA. Mol Ther 2011; 19: 2040-7
-
(2011)
Mol Ther
, vol.19
, pp. 2040-2047
-
-
Nakamura, K.1
Abu Lila, A.S.2
Matsunaga, M.3
Doi, Y.4
Ishida, T.5
Kiwada, H.6
-
132
-
-
57149142257
-
Co-delivery of siRNA and an anticancer drug for treatment of multidrug-resistant cancer
-
Saad M, Garbuzenko OB, Minko T. Co-delivery of siRNA and an anticancer drug for treatment of multidrug-resistant cancer. Nanomedicine (Lond) 2008; 3: 761-76
-
(2008)
Nanomedicine (Lond)
, vol.3
, pp. 761-776
-
-
Saad, M.1
Garbuzenko, O.B.2
Minko, T.3
-
133
-
-
84862779108
-
Bystander killing of malignant cells via the delivery of engineered thymidine-active deoxycytidine kinase for suicide gene therapy of cancer
-
Neschadim A, Wang JC, Lavie A, Medin JA. Bystander killing of malignant cells via the delivery of engineered thymidine-active deoxycytidine kinase for suicide gene therapy of cancer. Cancer Gene Ther 2012; 19: 320-7
-
(2012)
Cancer Gene Ther
, vol.19
, pp. 320-327
-
-
Neschadim, A.1
Wang, J.C.2
Lavie, A.3
Medin, J.A.4
-
134
-
-
3042773832
-
Combination of local, nonviral IL12 gene therapy and systemic paclitaxel treatment in a metastatic breast cancer model
-
Janat-Amsbury MM, Yockman JW, Lee M, et al. Combination of local, nonviral IL12 gene therapy and systemic paclitaxel treatment in a metastatic breast cancer model. Mol Ther 2004; 9: 829-36
-
(2004)
Mol Ther
, vol.9
, pp. 829-836
-
-
Janat-Amsbury, M.M.1
Yockman, J.W.2
Lee, M.3
-
135
-
-
84862815497
-
Multifunctional QD-based codelivery of siRNA and doxorubicin to HeLa cells for reversal of multidrug resistance and real-time tracking
-
Li JM, Wang YY, Zhao MX, et al. Multifunctional QD-based codelivery of siRNA and doxorubicin to HeLa cells for reversal of multidrug resistance and real-time tracking. Biomaterials 2012; 33: 2780-90
-
(2012)
Biomaterials
, vol.33
, pp. 2780-2790
-
-
Li, J.M.1
Wang, Y.Y.2
Zhao, M.X.3
-
136
-
-
78650134637
-
Engineered design of mesoporous silica nanoparticles to deliver doxorubicin and P-glycoprotein siRNA to overcome drug resistance in a cancer cell line
-
Meng H, Liong M, Xia T, et al. Engineered design of mesoporous silica nanoparticles to deliver doxorubicin and P-glycoprotein siRNA to overcome drug resistance in a cancer cell line. ACS Nano 2010; 4: 4539-50
-
(2010)
ACS Nano
, vol.4
, pp. 4539-4550
-
-
Meng, H.1
Liong, M.2
Xia, T.3
-
137
-
-
33645028210
-
Adenovirus-mediated p53 gene therapy in osteosarcoma cell lines: Sensitization to cisplatin and doxorubicin
-
Ganjavi H, Gee M, Narendran A, et al. Adenovirus-mediated p53 gene therapy in osteosarcoma cell lines: sensitization to cisplatin and doxorubicin. Cancer Gene Ther 2006; 13: 415-9
-
(2006)
Cancer Gene Ther
, vol.13
, pp. 415-419
-
-
Ganjavi, H.1
Gee, M.2
Narendran, A.3
-
138
-
-
84863579159
-
Synergistic treatment of ovarian cancer by co-delivery of survivin shRNA and paclitaxel via supramolecular micellar assembly
-
Hu Q, Li W, Hu X, et al. Synergistic treatment of ovarian cancer by co-delivery of survivin shRNA and paclitaxel via supramolecular micellar assembly. Biomaterials 2012; 33: 6580-91
-
(2012)
Biomaterials
, vol.33
, pp. 6580-6591
-
-
Hu, Q.1
Li, W.2
Hu, X.3
-
139
-
-
84946103243
-
AntiHER2/neu peptide-conjugated iron oxide nanoparticles for targeted delivery of paclitaxel to breast cancer cells
-
Mu Q, Kievit FM, Kant RJ, Lin G, Jeon M, Zhang M. AntiHER2/neu peptide-conjugated iron oxide nanoparticles for targeted delivery of paclitaxel to breast cancer cells. Nanoscale 2015; (10): 1056-8
-
(2015)
Nanoscale
, Issue.10
, pp. 1056-1058
-
-
Mu, Q.1
Kievit, F.M.2
Kant, R.J.3
Lin, G.4
Jeon, M.5
Zhang, M.6
-
140
-
-
84942428587
-
Phytosynthesis of gold nanoparticles using Mappia foetida leaves extract and their conjugation with folic acid for delivery of doxorubicin to cancer cells
-
Yallappa S, Manjanna J, Dhananjaya BL, Vishwanatha U, Ravishankar B, Gururaj H. Phytosynthesis of gold nanoparticles using Mappia foetida leaves extract and their conjugation with folic acid for delivery of doxorubicin to cancer cells. J Mater Sci Mater Med 2015; 26: 235
-
(2015)
J Mater Sci Mater Med
, vol.26
-
-
Yallappa, S.1
Manjanna, J.2
Dhananjaya, B.L.3
Vishwanatha, U.4
Ravishankar, B.5
Gururaj, H.6
-
141
-
-
84940572628
-
Effects of doxorubicin mediated by gold nanoparticles and resveratrol in two human cervical tumor cell lines
-
Tomoaia G, Horovitz O, Mocanu A, et al. Effects of doxorubicin mediated by gold nanoparticles and resveratrol in two human cervical tumor cell lines. Colloids Surf B Biointerfaces 2015; 135: 726-734
-
(2015)
Colloids Surf B Biointerfaces
, vol.135
, pp. 726-734
-
-
Tomoaia, G.1
Horovitz, O.2
Mocanu, A.3
-
142
-
-
84948395040
-
Polymergrafted mesoporous silica nanoparticles as ultrasound-responsive Drug Carriers
-
Paris JL, Cabanas MV, Manzano M, Vallet-Regi M. Polymergrafted mesoporous silica nanoparticles as ultrasound-responsive Drug Carriers. ACS Nano 2015; 9(11): 11023-33
-
(2015)
ACS Nano
, vol.9
, Issue.11
, pp. 11023-11033
-
-
Paris, J.L.1
Cabanas, M.V.2
Manzano, M.3
Vallet-Regi, M.4
-
143
-
-
84946866815
-
Theranostic etoposide phosphate/indium nanoparticles for cancer therapy and imaging
-
Srinivas R, Satterlee A, Wang Y, Zhang Y, Wang Y, Huang L. Theranostic etoposide phosphate/indium nanoparticles for cancer therapy and imaging. Nanoscale 2015; 7(44): 18542-51
-
(2015)
Nanoscale
, vol.7
, Issue.44
, pp. 18542-18551
-
-
Srinivas, R.1
Satterlee, A.2
Wang, Y.3
Zhang, Y.4
Wang, Y.5
Huang, L.6
-
144
-
-
84954510034
-
Methotrexate-conjugated quantum dots: Synthesis, characterisation and cytotoxicity in drug resistant cancer cells
-
Johari-Ahar M, Barar J, Alizadeh AM, Davaran S, Omidi Y, Rashidi MR. Methotrexate-conjugated quantum dots: synthesis, characterisation and cytotoxicity in drug resistant cancer cells. J Drug Target 2016; 24(2): 120-33
-
(2016)
J Drug Target
, vol.24
, Issue.2
, pp. 120-133
-
-
Johari-Ahar, M.1
Barar, J.2
Alizadeh, A.M.3
Davaran, S.4
Omidi, Y.5
Rashidi, M.R.6
-
145
-
-
84940744629
-
Carboxymethyl chitosan-mediated synthesis of hyaluronic acid-targeted graphene oxide for cancer drug delivery
-
Yang H, Bremner DH, Tao L, Li H, Hu J, Zhu L. Carboxymethyl chitosan-mediated synthesis of hyaluronic acid-targeted graphene oxide for cancer drug delivery. Carbohydr Polym 2016; 135: 72-8
-
(2016)
Carbohydr Polym
, vol.135
, pp. 72-78
-
-
Yang, H.1
Bremner, D.H.2
Tao, L.3
Li, H.4
Hu, J.5
Zhu, L.6
-
146
-
-
84879905115
-
The application of hyaluronic acidderivatized carbon nanotubes in hematoporphyrin monomethyl ether-based photodynamic therapy for in vivo and in vitro cancer treatment
-
Shi J, Ma R, Wang L, et al. The application of hyaluronic acidderivatized carbon nanotubes in hematoporphyrin monomethyl ether-based photodynamic therapy for in vivo and in vitro cancer treatment. Int J Nanomed 2013; 8: 2361-73
-
(2013)
Int J Nanomed
, vol.8
, pp. 2361-2373
-
-
Shi, J.1
Ma, R.2
Wang, L.3
-
147
-
-
84961704726
-
Preparation of pH-responsive mesoporous hydroxyapatite nanoparticles for intracellular controlled release of an anticancer drug
-
[Epub ahead of print]
-
Li D, Huang X, Wu Y, et al. Preparation of pH-responsive mesoporous hydroxyapatite nanoparticles for intracellular controlled release of an anticancer drug. Biomater Sci 2015; [Epub ahead of print]
-
(2015)
Biomater Sci
-
-
Li, D.1
Huang, X.2
Wu, Y.3
-
148
-
-
84945261471
-
Core-shell polymer nanoparticles for prevention of GSH drug detoxification and cisplatin delivery to breast cancer cells
-
Surnar B, Sharma K, Jayakannan M. Core-shell polymer nanoparticles for prevention of GSH drug detoxification and cisplatin delivery to breast cancer cells. Nanoscale 2015; 7: 17964-79
-
(2015)
Nanoscale
, vol.7
, pp. 17964-17979
-
-
Surnar, B.1
Sharma, K.2
Jayakannan, M.3
-
149
-
-
84899969356
-
Targeted poly (Lgamma-glutamyl glutamine) nanoparticles of docetaxel against folate over-expressed breast cancer cells
-
Tavassolian F, Kamalinia G, Rouhani H, et al. Targeted poly (Lgamma-glutamyl glutamine) nanoparticles of docetaxel against folate over-expressed breast cancer cells. Int J Pharm 2014; 467: 123-38
-
(2014)
Int J Pharm
, vol.467
, pp. 123-138
-
-
Tavassolian, F.1
Kamalinia, G.2
Rouhani, H.3
-
150
-
-
84924931849
-
Inhibition of MDR1 gene expression and enhancing cellular uptake for effective colon cancer treatment using dual-surface-functionalized nanoparticles
-
Xiao B, Zhang M, Viennois E, et al. Inhibition of MDR1 gene expression and enhancing cellular uptake for effective colon cancer treatment using dual-surface-functionalized nanoparticles. Biomaterials 2015; 48: 147-60
-
(2015)
Biomaterials
, vol.48
, pp. 147-160
-
-
Xiao, B.1
Zhang, M.2
Viennois, E.3
|